medical industry information

Global healthcare is being led by the  US with China  following close behind. Europe is simply being a spectator to the developments that are unfolding on a global level. The views were expressed by Roche CEO Severin Schwan at the “Entrepreneurship in Healthcare Powering Innovation” in Dublin, a European Healthcare Distribution Association (GIRP) initiative. Europe was criticized for its lack of efforts in expediting healthcare innovation in comparison to the speedy efforts of the US and China. With the establishment of a clear regulatory framework, the US has provided for a sustained roadmap for the rollout of new startup companies in the field. China is fast catching up with the US in this aspect. Europe will be facing increasing difficulties in catching up with the rest of the world in implementing innovative healthcare systems on account of fragmented data. The commitment of the Chinese to innovation is complete. They have evolved a long-term strategy for growth...

Boehringer Ingelheim is expanding its $77 million contract biologics China plant, making a notable bet that the kind of contract services it offers elsewhere will be a big draw to China too. This week, Boehringer Ingelheim BioXcellence said it has opened a new isolator-based fill-finish line at its commercial manufacturing unit in Shanghai, called OASIS which is in full compliance with the GMP operations for aseptic filling of liquids in vials. As a result of its new line, Boehringer now offers manufacturing of drug substances, drug products and all corresponding quality control and assurance activities at the one facility in China. Boehringer set foot in China in 1994 to build its biologics manufacturing plant and now employs over 3,500 people. The company’s decision to establish a biologics contract manufacturing operation in China was based on the country’s ever-growing population and their increased interest in new medicines.  As a result, the  $77 million facil...

It is positive news for the public that China is observing faster price cuts on oncology drugs. This major incident has taken place due to turmoil over a movie which revealed smugglers who were sneaking cheaper generic drugs into the country. This resulted in big pharma therapeutic drugs being targeted for cuts. The newly formed health insurance administration in China intend to deepen discounts on cancer drugs which were already on its National Reimbursement Drug List (NRDL) based on public bidding and procurement based on cancer therapies. In the meantime, officials will start enlisting negotiations for treatments which were not included on the coverage list. A novel dimension on cancer costs was declared in a government press conference, right before the removal of import tariffs and decreased import value-added tax to 3% on all commonly available cancer therapies. The Chinese government hopes that the drug companies will keep this decision in mind when fixing prices on the...

Recent scientific data revealed that the nonadherence to hepatitis B medicines increases the risk for hepatocellular carcinoma and cirrhosis followed by mortality. Neung Hwa Park, MD, PhD, from the University of Ulsan College of Medicine in the Republic of Korea said, “Adherence appears to be a key factor in minimizing [liver-related events (LRE); Considering that poor adherence increased the risk of LREs in this study, identifying an effective medical strategy to improve adherence to medication may substantially improve clinical outcomes.” The observational study was conducted among 894 chronic HBV patients who were given Baraclude (entecavir, Bristol-Myers Squibb) treatment for 10 years. After 10 years, only 296 patients had complete adherence; 617 patients had adherence rates lower or equal to 90%; 183 patients had between 70% to 90% adherence rates and 94 patients had adherence rate lower than 70%. The results also showed that people younger 30 years and ol...

Drugdu.com  Partners Recruitment Are  you a pharmaceutical /medical equipment salesman ?   Do you have an abundan ce   of high-quality client resources?   Do  you want to create your own business ?  Drugdu.com(   Ddu )   is the ideal platform for you. What is Drugdu.com  ( Ddu ) Drugdu.com  ( Ddu )  is an advanced global e-business trading platform for  cross-border medical commerce. We devote our efforts to break ing  the industry barriers to finding clients, establishing  cross-border trade  and building communication  channels.   W e also assist suppliers and buyers from all over the world to solidify international  business and provide complete solution s . Three iconic products for medical generalizing by Ddu   1.  Drugdu.com  ( Ddu )  Gold Member Ddu  gold member ship  provides professional promotion  service s  to assist medic...

Ddu is to attend CPhI China 2018 which will be grandly held at the Shanghai New Int'l Expo Centre (SNIEC), Shanghai, China. As the leading global pharmaceutical &  medical device products  B2B online platform, Ddu has been an exhibitor at CPhI in Shanghai for three consecutive years. If you are attending this exhibition, feel free to visit our booth at W5D16. As China's leading event for the pharmaceutical industry, CPhI China strives to provide a platform for local, regional and international buyers, manufacturers and suppliers to meet, do business and drive research and development in the Chinese pharmaceutical and healthcare industries. As the largest pharmaceutical exhibition in Asia, Shanghai CPhI exhibits raw materials, intermediates and fine chemicals, excipients and dosage forms, natural extracts, biological products, pharmaceutical preparations and animal health care. After years of efforts, CPhI Shanghai, which has been successfully held for 17 sessions, has...

Professor Emeritus Richard James along with medical glove makers Hartalega Malaysia and Chemical Intelligence, the R & D Company in the UK, has revealed that these new medical gloves would be the first non-leaching antimicrobial gloves in the world, in order to prevent the spread of infections. These novel medical gloves would include a new active microbe killing molecule as a prevention against germs. When tested, around 99.9% of all microbes were killed within five minutes. Professor James, the lead researcher said, “ These gloves will be a game-changer for the healthcare industry, both public and private. I am delighted that my lifetime’s research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future.” Mr. Kuan Mun Leong, the managing director of Hartalega Holdings, said, “ In the European Union alone, cross-contamination in hospitals results in 37,000 deaths a yea...